Quick Answer
BIOMARIN PHARMACEUTICAL INC reported Cash And Cash Equivalents At Carrying Value of $1.31 billion for the year ending 2025.
- BIOMARIN PHARMACEUTICAL INC showed an increase of +39.1% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from BIOMARIN PHARMACEUTICAL INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2007 to 2025 (19 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2009: $167.17 million | Q1 2010: $108.96 million | Q2 2010: $115.78 million | Q3 2010: $127.54 million | Q1 2011: $90.78 million | Q2 2011: $112.96 million | Q3 2011: $71.25 million | Q1 2012: $82.59 million | Q2 2012: $177.76 million | Q3 2012: $181.33 million | Q1 2013: $154.38 million | Q2 2013: $175.45 million | Q3 2013: $181.57 million | Q1 2014: $639.78 million | Q2 2014: $584.72 million | Q3 2014: $398.01 million | Q1 2015: $900.57 million | Q2 2015: $440.66 million | Q3 2015: $376.35 million | Q1 2016: $270.45 million | Q2 2016: $305.97 million | Q3 2016: $707.35 million | Q1 2017: $348.23 million | Q2 2017: $354.86 million | Q3 2017: $431.40 million | Q4 2017: $598.03 million | Q1 2018: $473.98 million | Q2 2018: $427.41 million | Q3 2018: $882.18 million | Q4 2018: $493.98 million | Q1 2019: $364.37 million | Q2 2019: $307.58 million | Q3 2019: $423.22 million | Q1 2020: $476.63 million | Q2 2020: $818.90 million | Q3 2020: $1.02 billion | Q1 2021: $667.31 million | Q2 2021: $641.53 million | Q3 2021: $617.14 million | Q1 2022: $605.44 million | Q2 2022: $619.80 million | Q3 2022: $761.52 million | Q1 2023: $580.07 million | Q2 2023: $694.38 million | Q3 2023: $785.41 million | Q1 2024: $747.00 million | Q2 2024: $972.15 million | Q3 2024: $675.45 million | Q1 2025: $1.05 billion | Q2 2025: $1.21 billion | Q3 2025: $1.25 billion.
- Over the full 19 years of available data (2007 to 2025), BIOMARIN PHARMACEUTICAL INC's Cash And Cash Equivalents At Carrying Value has grown by 474.4%.
- Historical annual values: Fiscal year 2025: $1.31 billion | Fiscal year 2024: $942.84 million | Fiscal year 2023: $755.13 million | Fiscal year 2022: $724.53 million | Fiscal year 2021: $587.28 million | Fiscal year 2020: $649.16 million | Fiscal year 2019: $437.45 million | Fiscal year 2018: $493.98 million | Fiscal year 2017: $598.03 million | Fiscal year 2016: $408.33 million | Fiscal year 2015: $397.04 million | Fiscal year 2014: $875.49 million | Fiscal year 2013: $568.78 million | Fiscal year 2012: $180.53 million | Fiscal year 2011: $46.27 million | Fiscal year 2010: $88.08 million | Fiscal year 2009: $167.17 million | Fiscal year 2008: $222.90 million | Fiscal year 2007: $228.34 million.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: